Actinium Pharmaceuticals, Inc. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Actinium Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Actinium Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -47.9 %, a 3.49% increase year-over-year.
  • Actinium Pharmaceuticals, Inc. annual Return On Assets for 2023 was -52.6 %, a 70.1% decline from 2022.
  • Actinium Pharmaceuticals, Inc. annual Return On Assets for 2022 was -30.9 %, a 1.18% decline from 2021.
  • Actinium Pharmaceuticals, Inc. annual Return On Assets for 2021 was -30.6 %, a 37.7% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -52.6 -21.7 -70.1% Jan 1, 2023 Dec 31, 2023
2022 -30.9 -0.36 -1.18% Jan 1, 2022 Dec 31, 2022
2021 -30.6 +18.5 +37.7% Jan 1, 2021 Dec 31, 2021
2020 -49 +92.2 +65.3% Jan 1, 2020 Dec 31, 2020
2019 -141 -24.8 -21.3% Jan 1, 2019 Dec 31, 2019
2018 -116 +32.9 +22.1% Jan 1, 2018 Dec 31, 2018
2017 -149 -34.4 -30% Jan 1, 2017 Dec 31, 2017
2016 -115 -29.1 -33.9% Jan 1, 2016 Dec 31, 2016
2015 -85.8 +148 +63.4% Jan 1, 2015 Dec 31, 2015
2014 -234 -6.22 -2.73% Jan 1, 2014 Dec 31, 2014
2013 -228 +350 +60.5% Jan 1, 2013 Dec 31, 2013
2012 -578 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.